BOS Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Sell
862
-71
-8% -$15.3K 0.05% 188
2026
Q1
$203K Buy
+933
New +$207K 0.05% 192
2025
Q4
Sell
-872
Closed -$202K 195
2025
Q3
$202K Buy
+872
New +$178K 0.06% 188
2024
Q4
Sell
-1,038
Closed -$205K 161
2024
Q3
$205K Buy
+1,038
New +$194K 0.08% 159

Other funds holding ABBV

BOS Asset Management's ABBV Position: Q2 2026 in Review

BOS Asset Management reduced its AbbVie (ABBV) stake by 7.6% in Q2 2026, selling an estimated $15.3K and leaving 862 shares worth $217K. The position accounts for 0.05% of the portfolio, ranked #188.

BOS Asset Management first reported a position in ABBV in Q3 2024 and has held it in 4 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BOS Asset Management held 862 shares of AbbVie worth $217K as of Q2 2026.
  • BOS Asset Management sold 71 AbbVie shares in Q2 2026, an estimated $15.3K.
  • AbbVie made up 0.05% of BOS Asset Management's portfolio in Q2 2026, its #188 holding.
  • BOS Asset Management first reported a position in AbbVie in Q3 2024 and has held it in 4 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BOS Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.